Risk of chemotherapy-induced febrile neutropenia in patients with metastatic cancer not receiving granulocyte colony-stimulating factor prophylaxis in US clinical practice

OBJECTIVES: To evaluate the use of granulocyte colony-stimulating factor (G-CSF) prophylaxis in US patients with selected metastatic cancers and chemotherapy-induced febrile neutropenia (FN) incidence and associated outcomes among the subgroup who did not receive prophylaxis. METHODS: This retrospec...

Descripción completa

Detalles Bibliográficos
Autores principales: Averin, Ahuva, Silvia, Amanda, Lamerato, Lois, Richert-Boe, Kathryn, Kaur, Manpreet, Sundaresan, Devi, Shah, Neel, Hatfield, Mark, Lawrence, Tatiana, Lyman, Gary H., Weycker, Derek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892737/
https://www.ncbi.nlm.nih.gov/pubmed/32880732
http://dx.doi.org/10.1007/s00520-020-05715-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892737/
https://www.ncbi.nlm.nih.gov/pubmed/32880732
http://dx.doi.org/10.1007/s00520-020-05715-3

Ejemplares similares